Cargando…
GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas
BACKGROUND: Bioenergetic characterisation of malignant tissues revealed that different tumour cells can catabolise multiple substrates as salvage pathways, in response to metabolic stress. Altered metabolism in gliomas has received a lot of attention, especially in relation to IDH mutations, and the...
Autores principales: | Hujber, Zoltán, Horváth, Gergő, Petővári, Gábor, Krencz, Ildikó, Dankó, Titanilla, Mészáros, Katalin, Rajnai, Hajnalka, Szoboszlai, Norbert, Leenders, William P. J., Jeney, András, Tretter, László, Sebestyén, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223071/ https://www.ncbi.nlm.nih.gov/pubmed/30404651 http://dx.doi.org/10.1186/s13046-018-0946-5 |
Ejemplares similares
-
Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells
por: Petővári, Gábor, et al.
Publicado: (2019) -
Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells
por: Petővári, Gábor, et al.
Publicado: (2018) -
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells
por: Hujber, Zoltán, et al.
Publicado: (2017) -
The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues
por: Sebestyén, Anna, et al.
Publicado: (2022) -
Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics
por: Krencz, Ildikó, et al.
Publicado: (2022)